Abstract
Chagas Disease (CD), a tropical parasitic disease caused by the flagellate protozoan Trypanosoma cruzi, accounts for the highest burden of parasitic diseases in the Western hemisphere. Current drug treatments for CD are highly toxic and often ineffective, particularly for the chronic stage of the disease, a fact that clearly emphasizes the importance of identification/validation of molecular targets for the development of new drugs to treat the disease. Here, we review in details the evidences that suggest the existence of specific receptors for platelet-activating factor (PAF) in T. cruzi, the role of PAF on the control of parasite differentiation and the potential of exploring these putative receptors as new targets for the chemotherapy of CD.
Keywords: Chagas disease, G-protein coupled receptors, phospholipids, platelet-activating factor, PAF receptors, Trypanosoma cruzi.
Mini-Reviews in Medicinal Chemistry
Title:Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease
Volume: 13 Issue: 7
Author(s): Daniel Fábio Kawano and Ivone Carvalho
Affiliation:
Keywords: Chagas disease, G-protein coupled receptors, phospholipids, platelet-activating factor, PAF receptors, Trypanosoma cruzi.
Abstract: Chagas Disease (CD), a tropical parasitic disease caused by the flagellate protozoan Trypanosoma cruzi, accounts for the highest burden of parasitic diseases in the Western hemisphere. Current drug treatments for CD are highly toxic and often ineffective, particularly for the chronic stage of the disease, a fact that clearly emphasizes the importance of identification/validation of molecular targets for the development of new drugs to treat the disease. Here, we review in details the evidences that suggest the existence of specific receptors for platelet-activating factor (PAF) in T. cruzi, the role of PAF on the control of parasite differentiation and the potential of exploring these putative receptors as new targets for the chemotherapy of CD.
Export Options
About this article
Cite this article as:
Fábio Kawano Daniel and Carvalho Ivone, Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease, Mini-Reviews in Medicinal Chemistry 2013; 13 (7) . https://dx.doi.org/10.2174/1389557511313070005
DOI https://dx.doi.org/10.2174/1389557511313070005 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Structure-Activity Relationship Studies on Holy Basil (Ocimum sanctum L.) Based Flavonoid Orientin and its Analogue for Cytotoxic Activity in Liver Cancer Cell Line HepG2
Combinatorial Chemistry & High Throughput Screening On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?
Current Neuropharmacology Latest Advances in Hydrogel-Based Drug Delivery Systems for Optimization of Metabolic Syndrome Treatment
Current Medicinal Chemistry Safety of Nanoparticles in Medicine
Current Drug Targets Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections
Coronaviruses Vascular Dementia: Atherosclerosis, Cognition and Alzheimers Disease
Current Alzheimer Research Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury
Current Pharmaceutical Biotechnology Secondary Prevention of Atherothrombotic Cerebrovascular Events
Current Vascular Pharmacology Cardiovascular Alterations After Spinal Cord Injury: An Overview
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Applications of Barton-McCombie Reaction in Total Syntheses
Current Organic Synthesis Effects of N-Acetyl-L-Cysteine and Hyaluronic Acid on HBOC-201- Induced Systemic and Cerebral Vasoconstriction in the Rat
Current Drug Discovery Technologies Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
Current Vascular Pharmacology Intravenous Immunoglobulin as a Potential Therapy for Refractory Urticaria - A Review
Inflammation & Allergy - Drug Targets (Discontinued) Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Stereospecific Synthesis of m-Hydroxymexiletine Enantiomers
Drug Metabolism Letters Recent Trends in Development of Fermented Milks
Current Nutrition & Food Science Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn
Current Drug Metabolism Effects of Estrogen in Gender-dependent Fetal Programming of Adult Cardiovascular Dysfunction
Current Vascular Pharmacology